1. Home
  2. ACHV vs ATOM Comparison

ACHV vs ATOM Comparison

Compare ACHV & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • ATOM
  • Stock Information
  • Founded
  • ACHV N/A
  • ATOM 2001
  • Country
  • ACHV United States
  • ATOM United States
  • Employees
  • ACHV N/A
  • ATOM N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ATOM Semiconductors
  • Sector
  • ACHV Health Care
  • ATOM Technology
  • Exchange
  • ACHV Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • ACHV 167.6M
  • ATOM 155.4M
  • IPO Year
  • ACHV N/A
  • ATOM 2016
  • Fundamental
  • Price
  • ACHV $3.17
  • ATOM $4.97
  • Analyst Decision
  • ACHV Strong Buy
  • ATOM
  • Analyst Count
  • ACHV 1
  • ATOM 0
  • Target Price
  • ACHV $12.00
  • ATOM N/A
  • AVG Volume (30 Days)
  • ACHV 727.0K
  • ATOM 552.2K
  • Earning Date
  • ACHV 11-06-2025
  • ATOM 10-28-2025
  • Dividend Yield
  • ACHV N/A
  • ATOM N/A
  • EPS Growth
  • ACHV N/A
  • ATOM N/A
  • EPS
  • ACHV N/A
  • ATOM N/A
  • Revenue
  • ACHV N/A
  • ATOM $49,000.00
  • Revenue This Year
  • ACHV N/A
  • ATOM N/A
  • Revenue Next Year
  • ACHV N/A
  • ATOM $700.00
  • P/E Ratio
  • ACHV N/A
  • ATOM N/A
  • Revenue Growth
  • ACHV N/A
  • ATOM N/A
  • 52 Week Low
  • ACHV $1.84
  • ATOM $3.06
  • 52 Week High
  • ACHV $5.31
  • ATOM $17.55
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 51.96
  • ATOM 61.09
  • Support Level
  • ACHV $3.07
  • ATOM $4.20
  • Resistance Level
  • ACHV $3.48
  • ATOM $5.35
  • Average True Range (ATR)
  • ACHV 0.15
  • ATOM 0.41
  • MACD
  • ACHV -0.01
  • ATOM 0.04
  • Stochastic Oscillator
  • ACHV 34.85
  • ATOM 73.94

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.

Share on Social Networks: